Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shot up 2% during trading on Tuesday . The company traded as high as $39.8270 and last traded at $39.8270. Approximately 401 shares were traded during mid-day trading, a decline of 72% from the average daily volume of 1,423 shares. The stock had previously closed at $39.05.
Hikma Pharmaceuticals Stock Performance
The stock’s 50 day simple moving average is $38.63 and its two-hundred day simple moving average is $39.14.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
